Free Online CME

Tuberculosis Testing in
the 21st Century: The Role of
Interferon-Gamma Release Assays

Webcast Series

Globally, infection with Mycobacterium tuberculosis (TB) is one of the leading causes of morbidity and mortality. Accurate diagnosis of latent TB is a key part of management strategies to improve patient health care outcomes associated with TB, especially in patients who receive immunosuppressive and biologic therapies. The webcast series,Tuberculosis Testing in the 21st Century: The Role of Interferon-Gamma Release Assays, is designed for health care professionals with an interest in a multidisciplinary approach to the screening and prevention of tuberculosis in these patients. Enhancements include downloadable audio and slide sets.

Print this Content

 

Webcasts

John J. Cush, MD
100 Years of TB Testing
John J. Cush, MD
Estimated Time: 30 minutes
Type: Webcast
Release Date: March 2, 2012
Expiration Date: March 2, 2015
Technical Requirements: Flash Player
Specialties: Rheumatology, Infectious Disease, Gastroenterology, Dermatology
Arthur Kavanaugh, MD
Estimated Time: 15 minutes
Type: Webcast
Release Date: March 2, 2012
Expiration Date: March 2, 2015
Technical Requirements: Flash Player
Specialties: Rheumatology, Infectious Disease, Gastroenterology, Dermatology
Xavier Mariette, MD
Estimated Time: 15 minutes
Type: Webcast
Release Date: March 2, 2012
Expiration Date: March 2, 2015
Technical Requirements: Flash Player
Specialties: Rheumatology, Infectious Disease, Gastroenterology, Dermatology
Kevin L. Winthrop MD, MPH
Tuberculosis in Twenty Minutes
Kevin L. Winthrop MD, MPH
Estimated Time: 30 minutes
Type: Webcast
Release Date: March 2, 2012
Expiration Date: March 2, 2015
Technical Requirements: Flash Player
Specialties: Rheumatology, Infectious Disease, Gastroenterology, Dermatology
Tuberculosis Testing in the 21st Century Interactive Case Discussion
Leonard Calabrese, DO; John J. Cush, MD; Arthur Kavanaugh, MD; Xavier Mariette, MD; Kevin L. Winthrop, MD
Estimated Time: 30 minutes
Type: Webcast
Release Date: March 2, 2012
Expiration Date: March 2, 2015
Technical Requirements: Flash Player
Specialties: Rheumatology, Infectious Disease, Gastroenterology, Dermatology

Series Objectives

  1. Summarize the global health policies, clinical strategies, and therapeutic issues involved in the diagnosis and management of latent tuberculosis infection.
  2. Describe the immunologic and technical basis of IGRA testing and discuss the characteristics of commercially available assays.
  3. Critically appraise current data on the comparative utility of IGRA testing in screening for latent TB in a population enriched with immunosuppressed patients.
  4. Apply appropriate clinical decision-making methods to case studies involving complex issue in TB management including anergy, BCG vaccination exposure, atypical Mycobacterial infections, and test conversion and reversion.

Target Audience

This activity is designed for rheumatologists, primary care physicians, and other clinicians, including allied health professionals, nurse practitioners, and physician assistants, who treat patients with rheumatic diseases.

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R. J. Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH